Regulation of vascular smooth muscle migration by mitogen-activated protein kinase and calcium/calmodulin-dependent protein kinase II signaling pathways

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 11, 1998, Pages 2377-2389

  Lundberg, Martha S ^a   Curto, Karen A ^a   Bilato, Claudio ^a   Monticone, Robert E ^a   Crow, Michael T ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Calcium calmodulin dependent protein kinase II; Cell migration; Integrins; MAPK; Platelet derived growth factor; Vascular smooth muscle cells

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE (CALCIUM,CALMODULIN) II; PROTEIN KINASE INHIBITOR;

ADENOVIRUS; ANIMAL CELL; AORTA MEDIA; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA;

EID: 0032213801     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0795     Document Type: Article

References (41)

1. ADAM LP, HATHAWAY DR, 1993. Identification of mitogen-activated protein kinase phosphorylation sequences in mammalian h-caldesmon. FEBS Lett 322: 56-60.
2. ALESSI DR, CUENDA A, COHEN P, DUDLEY DT, SALTIEL AR, 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270: 27489-27494.
3. ANAND-APTE B, ZETTER BR, VISWANATHAN A, QUI RG, CHEN J, RUGGIERI R, SYMONS M, 1997. Platelet-derived growth factor and fibronectin-stimulated migration are differentially regulated by the rac and extracellular signal-regulated kinase pathways. J Biol Chem 272: 30688-30692.
4. BILATO C, CROW MT, 1996. Atherosclerosis and the vascular biology of aging. Aging Clin Exp Res 8: 221-234.
5. BILATO C, PAULY RR, MELILLO G, MONTICONE R, GORELICK-FELDMAN D, GLUZBAND YA, SOLLOTT SJ, ZIMAN B, LAKATTA EG, CROW MT, 1995. Intracellular signaling pathways required for rat vascular smooth muscle cell migration. J Clin Invest 96: 1905-1915.
6. BILATO C, PAULY RR, CURTO KA, MONTICONE RE, WHITE AJ, CROW MT, 1997. The inhibition of vascular smooth muscle cell migration by antagonists of the vitronectin receptor is reversed through forced expression of activated calcium/calmodulin-dependent protein kinase II. J Clin Invest 100: 693-704.
7. BORNFELDT KE, RAINES EW, NAKANO T, GRAVES LM, KREBS EG, ROSS R, 1994. Insulin-like growth factor and PDGF-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest 93: 1266-1273.
8. BORNFELDT KE, RAINES EW, GRAVES LK SKINNER MP, KREBS EG, ROSS R, 1995. Platelet-derived growth factor: distinct signal transduction pathways associated with migration versus proliferation. Ann N Y Acad Sci 766: 416-430.
9. BOULTON TG, NYE SH, ROBBINS DJ, IP NY, RADZIEJEWSKA E, MORGENBESSER, SD, DEPINHO, RA, PANAYOTATOS N, COBB MH, YANCOPOULOS GD, 1991. ERKs: a family of proteinserine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65: 663-675.
10. CHOI ET, ENGEL L, CALLOW AD, SUN S, TRACHTENBERG J, SANTORO S, RYAN US, 1994. Inhibition of neointimal hyperplasia by blocking αvβ3 integrin with a small peptide antagonist GPenGRGDSPCA. J Vasc Surg 19: 125-134.
11. DELANEROLLE P, PAUL R, 1991. Myosin phosphorylation/dephosphorylation and regulation of airway smooth muscle contraction. Am J Physiol 261: L1-L14.
12. DEVORE J, 1982. Probability and Statistics for Engineering and the Sciences. Monterey, CA: Brooks/Cole Publishing Co.
13. DRECHSEL DN, HYMAN AA, COBB MH, KIRSCHNER MW, 1992. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol Biol Cell 3: 1141-1154.
14. DREWES G, LICHTENBERG-KRAAG B, DORING F, MANDELKOW EM, BIERNAT J, GORIS J, DOREE M, MANDELKOW E, 1992. Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J 11: 2131-2138.
15. FERNS GA, RAINES EW, SPRUGEL KH, MOTANI AS, REIDY MA, ROSS R, 1991. Inhibition of neointimal smooth muscle cell accumulation after angioplasty with an antibody to PDGF. Science 253: 1129-1132.
16. GRAF, K, XI X-P, YANG D, FLECK E, HSUEH WA, LAW RE, 1997. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration of vascular smooth muscle cells. Hypertension 29: 334-339.
17. HOSHIGA M, ALPERS CE, SMITH LL, GIACHELLI CM, SCHWARTZ SM, 1995. αvβ3 integrin expression in normal and atherosclerotic artery. Circ Res 77: 1129-1135.
18. JAWIEN A, BOWEN-POPE DF, LINDNER V, SCHWARTZ SM, CLOWES AW, 1992. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 89: 507-511.
19. KHALIL RA, MORGAN KG, 1993. PKC-mediated redistribution of mitogen-activated protein kinase during smooth muscle cell activation. Am J Physiol 265: C406-C411.
20. KHALIL RA, MENICE CB, WANG C-LA, MORGAN KG, 1995. Phosphotyrosine-dependent targeting of mitogen-activated protein kinase in differentiated contractile vascular cells. Circ Res 76: 1101-1108.
21. KLEMKE RL, CAI S, GIANNINI AL, GALLAGHER PJ, DELANEROLE P, CHRESH DA, 1997. Regulation of cell motility by mitogen activated protein kinase. J Cell Biol 137: 481-492.
22. 2+-ATPaSe activity of MyosinII. Biochem Biophys Res Comm 223: 741-745.
23. KUNDRA V, ANAND-APTE B, FEIG L, ZETTER B, 1995. The chemotactic response to PDGF-BB: evidence for a role of RAS. J Cell Biol 130: 725-731.
24. LINDNER V, REIDY MA, 1991. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 88: 3739-3743.
25. LINDNER V, LAPPI DA, BAIRD A, MAJACK RA, REIDY MA, 1991. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 68: 106-113.
26. MATUMO H, STASSEN JM, VERMYLEN J, DECKMYN H, 1994. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointimal formation. Circulation 90: 2203-2206.
27. MIYAMOTO S, TERAMOTO H, COSO OA, GUTKIND JS, BURBELO PD, AKIYAMA SK, YAMADA KM, 1995. Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. J Cell Biol 131: 791-805.
28. NAKIELNY S, COHEN P, WU J, STURGILL T, 1992. MAP kinase activator from insulin-stimulated skeletal muscle is a protein threonine/tyrosine kinase. EMBO J 11: 2123-2129.
29. NELSON PR, YAMAMURA S, MUREEBE L, HIROYUKI I, KENT KC, 1998. Smooth muscle cell migration and proliferation are mediated by distinct phases of activation of the intracellular messenger mitogen-activated protein kinase. J Vasc Surg 27: 117-125.
30. PAULY RR, PASSANITI A, BILATO C, MONTICONE R, CHENG L, PAPADOPOULOS N, GLUZBAND YA, SMITH L, WEINSTEIN C, LAKATTA EG, CROW MT, 1994. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res 75: 41-54.
31. PAULY RR, BILATO C, SOLLOT SJ, MONTICONE R, KELLY PT, LAKATTA EG, CROW, MT, 1995. Role of calcium/calmodulin-dependent protein kinase II in the regulation of vascular smooth muscle cell migration. Circulation 91: 1107-1115.
32. PAULY RR, BILATO C, CHENG L, MONTICONE R, CROW MT, 1998. Vascular smooth muscle cell cultures. Methods in Cell Biology 52: 133-154.
33. PAZIN MJ, WILLIAMS LT, 1992. Triggering signaling cascades by receptor tyrosine kinases. Trends Biochem Sci 17: 374-378.
34. PULVERER BJ, KYRIAKIS JM, AVRUCH J, NIKOLAKAKI E, WOODGETT JR, 1991. Phosphorylation of c-jun mediated by MAP kinases. Nature 353: 670-674.34.
35. RESZKA AA, SEGER R, DILITZ CD, KREBS EG, FISHER EH, 1995. Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc Natl Acad Sci USA 92: 8881-8885.
36. ROSS R, 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (London) 362: 801-809.
37. SEGER R, KREBS EG, 1995. The MAPK signaling cascade. FASEB J 9: 726-735.
38. STOSSEL TP, 1993. On the crawling of animal cells. Science (Wash DC) 260: 1086-1094.
39. TANSEY MG, WORD RA, HIDAKA H, SINGER HA, SCHWORER CM, KAMM KE, STULL JT, 1992. Phosphorylation of myosin light chain kinase by the multifunctional calcium/calmodulin-dependent protein kinase II in smooth muscle cells. J Biol Chem 267: 12511-12516.
40. TOKUMITSU H, CHIJIWA T, HAGIWARA M, MIZUTANI A, TERASAWA M, HIDAKA H, 1990. KN-62, 1-[N,O,-Bis (5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperizine, a specific inhibitor of Ca2+ /calmodulin-dependent protein kinase II. J Biol Chem 265: 4315-4320.
41. ZHANG Y, MORELAND S, MORELAND RS, 1994. Regulation of vascular smooth muscle contraction: myosin light chain phosphorylation dependent and independent pathways. Can J Physiol Pharmacol 72: 1386-1391.